A study of serum HMGB-1 levels in IPF patients found no significant difference between stable IPF patients and control subjects [71]; however, serum HMGB-1 level was lower in AE-IPF patients after PMX-DHP treatment [72]. This evidence concerns the gene HMGB1 and idiopathic pulmonary fibrosis.